Since these diseases have severe symptoms that lead to early death without treatment and these ExAC individuals are healthy (i.e., do not manifest severe Mendelian diseases) [23], the reported mutations are likely errors in pathogenicity classification or cases of incomplete penetrance (see a similar observation for CFTR and DHCR7 in [24]). This evidence concerns the gene CFTR and hereditary disease.